Contact Us
BLOG
>

Study evaluating the efficacy of bone marrow concentrate (BMC) in treating hip osteoarthritis.

This pilot study of 18 hips from 16 patients demonstrates that a single intra-articular injection of Bone Marrow Concentrate (BMC) serves as a safe biological bridge for symptomatic hip osteoarthritis, significantly reducing pain with activity (from 8 to 4.5) and at rest (from 5 to 1) while improving functional scores such as the mHHS (from 63 to 80) and HOS-ADL (from 71 to 85) over six months.

https://pubmed.ncbi.nlm.nih.gov/33344667

Share this post

Related Posts

Explore further insights and clinical perspectives on the topics discussed above.

x ray with knee
Level 1 study comparing 15-year outcomes of interosseous bone marrow concentrate injection (IO BMAC) vs total knee replacement (TKA) surgery for knee osteoarthritis.
In a landmark 15-year study of 140 patients between the ages of 65 and 90, researchers compared the outcomes of Total Knee Arthroplasty (TKA) in one knee against subchondral Bone Marrow Concentrate (BMC) injections in the other.
Learn More
prp knee injection
Comparison of ultrasound-guided (USG) versus palpation-guided AC joint injections: 2 cadaveric studies.
Two cadaveric studies show that ultrasound-guided (USG) injections significantly improve acromioclavicular (AC) joint placement accuracy.
Learn More
ha injection knee
Comparison of ultrasound-guided versus blind glenohumeral injections: a cadaveric study. 
In a controlled study involving 80 cadaveric shoulder injections, experienced surgeons compared the efficacy of two guidance methods using a posterior approach.
Learn More
View More

Get Back to What You Love

Schedule a consultation to explore non-surgical treatment options that align with your active lifestyle.

Schedule Your Consultation